Gynecology/Obstetrics and Neonatal
Cervical Cytology
January 1999
Clinical Focus*
- What is the accuracy of cervical cytology using conventional Pap smears and new technologies (thin-layer cytology, computer rescreening, algorithm-based decisionmaking technology) for detecting cervical cancer and its precursors?
- What are the direct medical costs associated with cervical cancer screening, evaluation, treatment, and followup of cervical cytological abnormalities and treatment and followup of cervical cancer?
- What are the effects on total health care cost, morbidity, and mortality of regular cervical cytological screening using thin-layer cytology and computer rescreening using neural network or algorithm-based decisionmaking technology compared with the conventional Pap smear in women participating in a screening program?
*Addressed in the summary or evidence report.
Evaluation of Cervical Cytology
Summary (Publication No. 99-E009, January 1999)
Evidence Report (Publication No. 99-E010, April 1999)
Selected Publications
EPC: Duke University
Topic Nominator: American College of Obstetricians and Gynecologists
Return to Quick Menu: Evidence Report Topics
Return to Evidence-based Practice